• Høyt nivå av lipoprotein(a) – utredning og behandling 

      Svilaas, Tone; Klemsdal, Tor Ole; Bogsrud, Martin Prøven; Græsdal, Asgeir; Vesterbekkmo, Elisabeth Kleivhaug; Asprusten, Emil Andreas; Langslet, Gisle; Retterstøl, Kjetil (Peer reviewed; Journal article, 2022)
      Omtrent 5 % av befolkningen har betydelig forhøyet verdi av lipoprotein(a) (Lp(a)), som er en arvelig betinget risikofaktor for hjerte- og karsykdom. Måling av lipoprotein(a) kan bedre kardiovaskulær risikostratifisering ...
    • Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia 

      Klevmoen, Marianne; Bogsrud, Martin Prøven; Retterstøl, Kjetil; Svilaas, Tone; Vesterbekkmo, Elisabeth Kleivhaug; Hovland, Anders; Berge, Christ; van Lennep, Jeanine Roeters; Holven, Kirsten Bjørklund (Peer reviewed; Journal article, 2021)
      Background and aims Women with heterozygous familial hypercholesterolemia (FH) are recommended to initiate statin treatment at the same age as men (from 8 to 10 years of age). However, statins are contraindicated when ...
    • Profiling of immune-related gene expression in children with familial hypercholesterolaemia 

      Narverud, Ingunn; Christensen, Jacob J.; Bakke, Siril Skaret; Ulven, Stine Marie; Rundblad, Amanda; Aukrust, Pål; Espevik, Terje; Bogsrud, Martin Prøven; Retterstøl, Kjetil; Ueland, Thor; Halvorsen, Bente; Holven, Kirsten Bjørklund (Journal article; Peer reviewed, 2019)
      Background Innate and adaptive immune responses are pivotal in atherosclerosis, but their association with early‐stage atherosclerosis in humans is incompletely understood. In this regard, untreated children with familial ...